Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M et al (2003) Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial—the zoledronic acid lung cancer and other solid tumors study group. J Clin Oncol 21:3150–3157. https://doi.org/10.1200/JCO.2003.04.105. (PubMed PMID: 12915606)

Article  CAS  PubMed  Google Scholar 

Nervo A, Ragni A, Retta F, Gallo M, Piovesan A, Liberini V et al (2021) Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues. J Endocrinol Invest 44:403–419. https://doi.org/10.1007/s40618-020-01374-7

Article  CAS  PubMed  Google Scholar 

Yong M, Jensen AØ, Jacobsen JB, Nørgaard M, Fryzek JP, Sørensen HT (2011) Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007). Breast Cancer Res Treat 129:495–503. https://doi.org/10.1007/s10549-011-1475-5

Article  PubMed  Google Scholar 

Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V et al (2012) Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006. Breast Cancer Res Treat 131:231–238. https://doi.org/10.1007/s10549-011-1721-x

Article  CAS  PubMed  Google Scholar 

Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C et al (2012) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7:1823–1829. https://doi.org/10.1097/JTO.0b013e31826aec2b

Article  CAS  PubMed  Google Scholar 

Shinoda Y, Sawada R, Yoshikawa F, Oki T, Hirai T, Kobayashi H et al (2019) Factors related to the quality of life in patients with bone metastases. Clin Exp Metastasis 36:441–448. https://doi.org/10.1007/s10585-019-09983-0

Article  CAS  PubMed  Google Scholar 

Choksi P, Papaleontiou M, Guo C, Worden F, Banerjee M, Haymart M (2017) Skeletal complications and mortality in thyroid cancer: a population-based study. J Clin Exp Metab 102:1254–1260. https://doi.org/10.1210/jc.2016-3906

Article  Google Scholar 

Wu D, Gomes Lima CJ, Moreau SL, Kulkarni K, Zeymo A, Burman KD et al (2019) Improved survival after multimodal approach with 131I treatment in patients with bone metastases secondary to differentiated thyroid cancer. Thyroid 29:971–978. https://doi.org/10.1089/thy.2018.0582

Article  PubMed  Google Scholar 

Lipton A, Fizazi K, Stopeck AT, Henry DH, Brown JE, Yardley DA et al (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48:3082–3092. https://doi.org/10.1016/j.ejca.2012.08.002

Article  CAS  PubMed  Google Scholar 

Polizzotto MN, Cousins V, Schwarer AP (2006) Bisphosphonate-associated osteonecrosis of the auditory canal. Br J Haematol 132:114. https://doi.org/10.1111/j.1365-2141.2005.05833.x

Article  PubMed  Google Scholar 

Froelich K, Radeloff A, Köhler C, Mlynski R, Müller J, Hagen R et al (2011) Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study. Eur Arch Otorhinolaryngol 268:1219–1225. https://doi.org/10.1007/s00405-011-1496-z

Article  CAS  PubMed  Google Scholar 

Kharazmi M, Hallberg P, Persson U, Warfvinge G (2013) Bisphosphonate-associated osteonecrosis of the auditory canal. Br J Oral Maxillofac Surg 51:e285–e287. https://doi.org/10.1016/j.bjoms.2013.02.013

Article  PubMed  Google Scholar 

Salzman R, Hoza J, Perina V, Stárek I (2013) Osteonecrosis of the external auditory canal associated with oral bisphosphonate therapy: case report and literature review. Otol Neurotol 34:209–213. https://doi.org/10.1097/mao.0b013e31827ca34d

Article  PubMed  Google Scholar 

Wickham N, Crawford A, Carney A, Goss A (2013) Bisphosphonate-associated osteonecrosis of the external auditory canal. J Laryngol Otol 127:S51–S53. https://doi.org/10.1017/S002221511300100X

Article  PubMed  Google Scholar 

Thorsteinsson A, Lomholt A, Eiken P (2015) Bisphosphonate-induced osteonecrosis of the external auditory canal: a case report. J Clin Med Case Reports 2:3

Google Scholar 

McCadden L, Leonard C, Primrose W (2018) Bisphosphonate-induced osteonecrosis of the ear canal: our experience and a review of the literature. J Laryngol Otol 132(4):372–374. https://doi.org/10.1017/S0022215118000324

Article  CAS  PubMed  Google Scholar 

Takeda T, Ito T, Onishi I, Yokomura M, Kawashima Y, Fujikawa T et al (2021) Denosumab-induced osteonecrosis of external auditory canal. Auris Nasus Larynx 48:1199–1203. https://doi.org/10.1016/j.anl.2020.07.007

Article  PubMed  Google Scholar 

True HD, Ricks RG, Smith JA (2021) Denosumab and bisphosphonate associated bilateral osteonecrosis of the external auditory canal. BMJ Case Rep 14:e241203. https://doi.org/10.1136/bcr-2020-241203

Article  PubMed  PubMed Central  Google Scholar 

Peřina V, Salzman R, Treglerová J (2021) Denosumab-related osteonecrosis of the external auditory canal-benefit of the early surgical management. Ear Nose Throat J 103:277–281. https://doi.org/10.1177/01455613211053389

Article  PubMed  Google Scholar 

Kumar S, Diamond T, Walton J (2023) Two cases of external auditory canal osteonecrosis in patients on antiresorptive therapy for osteoporosis. JCEM Case Rep. https://doi.org/10.1210/jcemcr/luad021

Article  PubMed  PubMed Central  Google Scholar 

VanDolah H, Crossley JR, Kim HJ (2023) Three cases of uncommon medication-associated osteonecrosis of temporal bone. World J Otorhinolaryngol Head Neck Surg 10:237–240. https://doi.org/10.1002/wjo2.146

Article  PubMed  PubMed Central  Google Scholar 

Mayer AW, Oladokun D, Mistry D (2024) Recognizing bisphosphonate-induced ear osteonecrosis in primary care: a case report. Fam Pract 41:219–222. https://doi.org/10.1093/fampra/cmae012

Article  PubMed  Google Scholar 

Thorsteinsson AL, Vestergaard P, Eiken P (2014) External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review. Osteoporos Int 25:1937–1944. https://doi.org/10.1007/s00198-014-2684-7

Article  CAS  PubMed  Google Scholar 

Costa AG, Bilezikian JP (2015) How long to treat with denosumab. Curr Osteoporos Rep Curr Osteoporos Rep 13:415–420. https://doi.org/10.1007/s11914-015-0295-7

Article  PubMed  Google Scholar 

Stopeck AT, Fizazi K, Body J-J, Brown JE, Carducci M, Diel I et al (2016) Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Support Care Cancer 24:447–455. https://doi.org/10.1007/s00520-015-2904-5

Article  PubMed  Google Scholar 

Iñiguez-Ariza NM, Bible KC, Clarke BL (2020) Bone metastases in thyroid cancer. J Bone Oncol 21:100282. https://doi.org/10.1016/j.jbo.2020.100282

Article  PubMed  PubMed Central  Google Scholar 

Nakayama R, Horiuchi K, Susa M, Watanabe I, Watanabe K, Tsuji T et al (2014) Clinical outcome after bone metastasis (BM) surgery in patients with differentiated thyroid carcinoma (DTC): a retrospective study of 40 cases. Jpn J Clin Oncol 44:918–925. https://doi.org/10.1093/jjco/hyu099

Article  PubMed  Google Scholar 

Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A et al (2018) Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. Endocrine 59:90–101. https://doi.org/10.1007/s12020-017-1455-6

Article  CAS  PubMed  Google Scholar 

Farooki A, Leung V, Tala H, Tuttle RM (2012) Skeletal-related events due to bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab 97:2433–2439

Article  CAS  PubMed  Google Scholar 

Orita Y, Sugitani I, Toda K, Manabe J, Fujimoto Y (2011) Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid 21:31–35. https://doi.org/10.1089/thy.2010.0169